vs
PREFORMED LINE PRODUCTS CO（PLPC）与U S PHYSICAL THERAPY INC（USPH）财务数据对比。点击上方公司名可切换其他公司
U S PHYSICAL THERAPY INC的季度营收约是PREFORMED LINE PRODUCTS CO的1.2倍（$202.7M vs $173.1M），PREFORMED LINE PRODUCTS CO净利率更高（4.9% vs 2.0%，领先2.8%），U S PHYSICAL THERAPY INC同比增速更快（12.3% vs 3.6%），U S PHYSICAL THERAPY INC自由现金流更多（$21.0M vs $11.8M），过去两年U S PHYSICAL THERAPY INC的营收复合增速更高（14.1% vs 10.8%）
预成型线路产品公司（PLPC）研发、生产和销售适用于输配电、通信及可再生能源基建领域的工程硬件组件，服务全球多地的公用事业、网络运营商及工业客户，提供可提升网络可靠性与运营效率的解决方案。
该企业是美国领先的门诊康复服务提供商，运营数百间线下物理治疗门诊，为受伤、术后、慢性疼痛及行动障碍人群提供康复护理，同时覆盖运动医学、职业治疗、儿童康复等特色服务领域。
PLPC vs USPH — 直观对比
营收规模更大
USPH
是对方的1.2倍
$173.1M
营收增速更快
USPH
高出8.8%
3.6%
净利率更高
PLPC
高出2.8%
2.0%
自由现金流更多
USPH
多$9.2M
$11.8M
两年增速更快
USPH
近两年复合增速
10.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $173.1M | $202.7M |
| 净利润 | $8.4M | $4.2M |
| 毛利率 | 29.8% | 19.8% |
| 营业利润率 | 6.8% | 8.3% |
| 净利率 | 4.9% | 2.0% |
| 营收同比 | 3.6% | 12.3% |
| 净利润同比 | -19.3% | -55.1% |
| 每股收益（稀释后） | $1.72 | $-0.44 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PLPCUSPH
| Q4 25 | $173.1M | $202.7M | ||
| Q3 25 | $178.1M | $197.1M | ||
| Q2 25 | $169.6M | $197.3M | ||
| Q1 25 | $148.5M | $183.8M | ||
| Q4 24 | $167.1M | $180.4M | ||
| Q3 24 | $147.0M | $168.0M | ||
| Q2 24 | $138.7M | $167.2M | ||
| Q1 24 | $140.9M | $155.7M |
净利润PLPCUSPH
| Q4 25 | $8.4M | $4.2M | ||
| Q3 25 | $2.6M | $13.1M | ||
| Q2 25 | $12.7M | $12.4M | ||
| Q1 25 | $11.5M | $9.9M | ||
| Q4 24 | $10.5M | $9.2M | ||
| Q3 24 | $7.7M | $6.6M | ||
| Q2 24 | $9.4M | $7.5M | ||
| Q1 24 | $9.6M | $8.0M |
毛利率PLPCUSPH
| Q4 25 | 29.8% | 19.8% | ||
| Q3 25 | 29.7% | 18.7% | ||
| Q2 25 | 32.7% | 21.1% | ||
| Q1 25 | 32.8% | 16.9% | ||
| Q4 24 | 33.3% | 18.0% | ||
| Q3 24 | 31.1% | 17.3% | ||
| Q2 24 | 31.9% | 20.3% | ||
| Q1 24 | 31.3% | 18.2% |
营业利润率PLPCUSPH
| Q4 25 | 6.8% | 8.3% | ||
| Q3 25 | 7.4% | 12.8% | ||
| Q2 25 | 10.1% | 12.6% | ||
| Q1 25 | 8.8% | 10.7% | ||
| Q4 24 | 10.5% | 10.9% | ||
| Q3 24 | 7.1% | 7.6% | ||
| Q2 24 | 8.1% | 9.3% | ||
| Q1 24 | 8.2% | 9.6% |
净利率PLPCUSPH
| Q4 25 | 4.9% | 2.0% | ||
| Q3 25 | 1.5% | 6.7% | ||
| Q2 25 | 7.5% | 6.3% | ||
| Q1 25 | 7.8% | 5.4% | ||
| Q4 24 | 6.3% | 5.1% | ||
| Q3 24 | 5.2% | 3.9% | ||
| Q2 24 | 6.8% | 4.5% | ||
| Q1 24 | 6.8% | 5.2% |
每股收益（稀释后）PLPCUSPH
| Q4 25 | $1.72 | $-0.44 | ||
| Q3 25 | $0.53 | $0.48 | ||
| Q2 25 | $2.56 | $0.58 | ||
| Q1 25 | $2.33 | $0.80 | ||
| Q4 24 | $2.13 | $0.52 | ||
| Q3 24 | $1.54 | $0.39 | ||
| Q2 24 | $1.89 | $0.47 | ||
| Q1 24 | $1.94 | $0.46 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $35.6M |
| 总债务越低越好 | $38.3M | — |
| 股东权益账面价值 | $475.5M | $476.4M |
| 总资产 | $653.6M | $1.2B |
| 负债/权益比越低杠杆越低 | 0.08× | — |
8季度趋势，按日历期对齐
现金及短期投资PLPCUSPH
| Q4 25 | — | $35.6M | ||
| Q3 25 | — | $31.1M | ||
| Q2 25 | — | $34.1M | ||
| Q1 25 | — | $39.2M | ||
| Q4 24 | — | $41.4M | ||
| Q3 24 | — | $117.0M | ||
| Q2 24 | — | $112.9M | ||
| Q1 24 | — | $132.3M |
总债务PLPCUSPH
| Q4 25 | $38.3M | — | ||
| Q3 25 | $36.0M | — | ||
| Q2 25 | $31.8M | — | ||
| Q1 25 | $29.1M | — | ||
| Q4 24 | $20.8M | — | ||
| Q3 24 | $27.2M | — | ||
| Q2 24 | $31.6M | — | ||
| Q1 24 | $55.0M | — |
股东权益PLPCUSPH
| Q4 25 | $475.5M | $476.4M | ||
| Q3 25 | $466.3M | $503.6M | ||
| Q2 25 | $460.7M | $500.8M | ||
| Q1 25 | $435.8M | $497.3M | ||
| Q4 24 | $422.3M | $488.9M | ||
| Q3 24 | $429.0M | $482.8M | ||
| Q2 24 | $416.2M | $484.6M | ||
| Q1 24 | $413.4M | $479.8M |
总资产PLPCUSPH
| Q4 25 | $653.6M | $1.2B | ||
| Q3 25 | $644.6M | $1.2B | ||
| Q2 25 | $631.5M | $1.2B | ||
| Q1 25 | $592.5M | $1.2B | ||
| Q4 24 | $573.9M | $1.2B | ||
| Q3 24 | $592.0M | $1.0B | ||
| Q2 24 | $572.6M | $1.0B | ||
| Q1 24 | $586.1M | $1.0B |
负债/权益比PLPCUSPH
| Q4 25 | 0.08× | — | ||
| Q3 25 | 0.08× | — | ||
| Q2 25 | 0.07× | — | ||
| Q1 25 | 0.07× | — | ||
| Q4 24 | 0.05× | — | ||
| Q3 24 | 0.06× | — | ||
| Q2 24 | 0.08× | — | ||
| Q1 24 | 0.13× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $21.9M | $24.9M |
| 自由现金流经营现金流 - 资本支出 | $11.8M | $21.0M |
| 自由现金流率自由现金流/营收 | 6.8% | 10.4% |
| 资本支出强度资本支出/营收 | 5.9% | 1.9% |
| 现金转化率经营现金流/净利润 | 2.60× | 6.00× |
| 过去12个月自由现金流最近4个季度 | $33.3M | $61.0M |
8季度趋势，按日历期对齐
经营现金流PLPCUSPH
| Q4 25 | $21.9M | $24.9M | ||
| Q3 25 | $18.9M | $19.9M | ||
| Q2 25 | $26.9M | $34.9M | ||
| Q1 25 | $5.7M | $-4.7M | ||
| Q4 24 | $24.1M | $19.4M | ||
| Q3 24 | $9.4M | $22.1M | ||
| Q2 24 | $28.3M | $29.0M | ||
| Q1 24 | $5.8M | $4.4M |
自由现金流PLPCUSPH
| Q4 25 | $11.8M | $21.0M | ||
| Q3 25 | $8.3M | $15.6M | ||
| Q2 25 | $18.6M | $31.6M | ||
| Q1 25 | $-5.3M | $-7.3M | ||
| Q4 24 | $20.6M | $16.9M | ||
| Q3 24 | $5.8M | $19.6M | ||
| Q2 24 | $24.6M | $26.7M | ||
| Q1 24 | $1.8M | $2.6M |
自由现金流率PLPCUSPH
| Q4 25 | 6.8% | 10.4% | ||
| Q3 25 | 4.7% | 7.9% | ||
| Q2 25 | 10.9% | 16.0% | ||
| Q1 25 | -3.6% | -3.9% | ||
| Q4 24 | 12.3% | 9.4% | ||
| Q3 24 | 3.9% | 11.7% | ||
| Q2 24 | 17.7% | 15.9% | ||
| Q1 24 | 1.3% | 1.7% |
资本支出强度PLPCUSPH
| Q4 25 | 5.9% | 1.9% | ||
| Q3 25 | 6.0% | 2.2% | ||
| Q2 25 | 4.9% | 1.6% | ||
| Q1 25 | 7.4% | 1.4% | ||
| Q4 24 | 2.1% | 1.4% | ||
| Q3 24 | 2.4% | 1.5% | ||
| Q2 24 | 2.7% | 1.4% | ||
| Q1 24 | 2.8% | 1.2% |
现金转化率PLPCUSPH
| Q4 25 | 2.60× | 6.00× | ||
| Q3 25 | 7.21× | 1.52× | ||
| Q2 25 | 2.12× | 2.81× | ||
| Q1 25 | 0.49× | -0.47× | ||
| Q4 24 | 2.30× | 2.10× | ||
| Q3 24 | 1.22× | 3.34× | ||
| Q2 24 | 3.02× | 3.86× | ||
| Q1 24 | 0.60× | 0.55× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PLPC
暂无分部数据
USPH
| Net Patient Revenues | $169.7M | 84% |
| Industrial Injury Prevention Services Revenues | $28.9M | 14% |
| Management Contract Revenues | $2.3M | 1% |
